The global components crisis has taught the electronics industry a hard lesson: reacting to a shortage is far more expensive than anticipating it. This is especially true in medical devices, where a component can’t simply be swapped for an equivalent one: any change to the Bill of Materials can trigger a new regulatory re-verification, delaying certification and, with it, the launch.
One of our customers, a manufacturer of a certified medical device, was preparing to move into mass production and needed certainty that its supply chain could sustain the ramp-up without interruptions once manufacturing had started.

The requirements to be solved were the following:

Our Purchase Department and Product Engineering team carried out a line-by-line audit of the customer’s BOM: lifecycle status (active, NRND, EOL), sourcing depth (single vs. multi-source), traceability through authorized distributors to rule out counterfeit risk, and lead-time exposure per component.
For every line flagged as high risk, our engineers pre-qualified alternate components that were compatible with the device’s existing regulatory file, so that if a shortage hit, the customer could react without opening a new certification process.

Solsonès, 87 – P. I. Pla de la Bruguera
08211 Castellar del Vallès. Barcelona


